Xiaodan Mai1, Michael J LaMonte1, Kathleen M Hovey1, Jo L Freudenheim1, Christopher A Andrews2, Robert J Genco3, Jean Wactawski-Wende4. 1. Department of Epidemiology and Environmental Health, University at Buffalo, State University of New York, Buffalo, NY, USA. 2. Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, MI, USA. 3. Department of Oral Biology, University at Buffalo, State University of New York, Buffalo, NY, USA. 4. Department of Epidemiology and Environmental Health, University at Buffalo, State University of New York, Buffalo, NY, USA. jww@buffalo.edu.
Abstract
PURPOSE: Few prospective studies have reported on relationships between objective periodontal disease (PD) measures and cancer risk. This association was examined in 1,337 postmenopausal women participating in the Buffalo OsteoPerio Study. METHODS: Oral alveolar crestal height (ACH) was measured using oral radiographs. Incident cancers were adjudicated with medical records. Hazard ratios (HRs) and 95 % confidence intervals (CIs) for associations between ACH and incident cancer outcomes were estimated using Cox proportional hazards models. RESULTS: There were 203 confirmed total incident cancer cases during follow-up (12.2 ± 4.2 years). After adjusting for age and smoking, there were no statistically significant associations between ACH-defined PD categories and total cancer risk (mild/moderate vs. none: HR 1.33, 95 % CI 0.91-1.94; severe vs. none: HR 1.20, 95 % CI 0.77-1.86). ACH-defined PD categories were not associated with common site-specific cancers. Whole-mouth mean and worst-site ACH (per 1 mm loss) were significantly associated with increased risk of lung (adjusted HR 1.81, 95 % CI 1.30-2.54; adjusted HR 1.34, 95 % CI 1.08-1.66, respectively), but not total or other site-specific cancer. Smoking status modified the associations between continuous ACH variables and total cancer risk; measures of PD were associated with total cancer among smokers but not never smokers (interaction p = 0.02 and p < 0.01 for whole-mouth mean and worst-site ACH, respectively). CONCLUSIONS: ACH-defined PD was associated with total cancer risk in ever but not never smoking postmenopausal women. Whole-mouth mean and worst-site ACH were associated with increased lung cancer risk. However, these results need to be interpreted cautiously given the small number of lung cancer cases (n = 18). Further research utilizing a larger sample is warranted to confirm the relationships among oral bone loss, site-specific cancers, and total cancer.
PURPOSE: Few prospective studies have reported on relationships between objective periodontal disease (PD) measures and cancer risk. This association was examined in 1,337 postmenopausal women participating in the Buffalo OsteoPerio Study. METHODS:Oral alveolar crestal height (ACH) was measured using oral radiographs. Incident cancers were adjudicated with medical records. Hazard ratios (HRs) and 95 % confidence intervals (CIs) for associations between ACH and incident cancer outcomes were estimated using Cox proportional hazards models. RESULTS: There were 203 confirmed total incident cancer cases during follow-up (12.2 ± 4.2 years). After adjusting for age and smoking, there were no statistically significant associations between ACH-defined PD categories and total cancer risk (mild/moderate vs. none: HR 1.33, 95 % CI 0.91-1.94; severe vs. none: HR 1.20, 95 % CI 0.77-1.86). ACH-defined PD categories were not associated with common site-specific cancers. Whole-mouth mean and worst-site ACH (per 1 mm loss) were significantly associated with increased risk of lung (adjusted HR 1.81, 95 % CI 1.30-2.54; adjusted HR 1.34, 95 % CI 1.08-1.66, respectively), but not total or other site-specific cancer. Smoking status modified the associations between continuous ACH variables and total cancer risk; measures of PD were associated with total cancer among smokers but not never smokers (interaction p = 0.02 and p < 0.01 for whole-mouth mean and worst-site ACH, respectively). CONCLUSIONS:ACH-defined PD was associated with total cancer risk in ever but not never smoking postmenopausal women. Whole-mouth mean and worst-site ACH were associated with increased lung cancer risk. However, these results need to be interpreted cautiously given the small number of lung cancer cases (n = 18). Further research utilizing a larger sample is warranted to confirm the relationships among oral bone loss, site-specific cancers, and total cancer.
Entities:
Keywords:
Alveolar bone loss; Cancer epidemiology; Inflammation; Periodontal disease; Postmenopausal women; Prospective studies
Authors: Jennifer Hays; Julie R Hunt; F Allan Hubbell; Garnet L Anderson; Marian Limacher; Catherine Allen; Jacques E Rossouw Journal: Ann Epidemiol Date: 2003-10 Impact factor: 3.797
Authors: J David Curb; Anne McTiernan; Susan R Heckbert; Charles Kooperberg; Janet Stanford; Michael Nevitt; Karen C Johnson; Lori Proulx-Burns; Lisa Pastore; Michael Criqui; Sandra Daugherty Journal: Ann Epidemiol Date: 2003-10 Impact factor: 3.797
Authors: Christian C Abnet; Farin Kamangar; Sanford M Dawsey; Rachael Z Stolzenberg-Solomon; Demetrius Albanes; Pirjo Pietinen; Jarmo Virtamo; Philip R Taylor Journal: Scand J Gastroenterol Date: 2005-06 Impact factor: 2.423
Authors: Haydée Wt Jordão; Gerry McKenna; Úna C McMenamin; Andrew T Kunzmann; Liam J Murray; Helen G Coleman Journal: United European Gastroenterol J Date: 2019-06-08 Impact factor: 4.623
Authors: Kimberly A Bertrand; Janki Shingala; Andrew Evens; Brenda M Birmann; Edward Giovannucci; Dominique S Michaud Journal: Int J Cancer Date: 2016-11-25 Impact factor: 7.396
Authors: Jiayun Lu; Ina Zaimi; John R Barber; Corinne E Joshu; Anna E Prizment; James D Beck; Elizabeth A Platz; Dominique S Michaud Journal: Ann Epidemiol Date: 2019-08-22 Impact factor: 3.797
Authors: Dominique S Michaud; Jiayun Lu; Alexandra Y Peacock-Villada; John R Barber; Corinne E Joshu; Anna E Prizment; James D Beck; Steven Offenbacher; Elizabeth A Platz Journal: J Natl Cancer Inst Date: 2018-08-01 Impact factor: 13.506
Authors: Laura Corlin; Mengyuan Ruan; Konstantinos K Tsilidis; Emmanouil Bouras; Yau-Hua Yu; Rachael Stolzenberg-Solomon; Alison P Klein; Harvey A Risch; Christopher I Amos; Lori C Sakoda; Pavel Vodička; Pai K Rish; James Beck; Elizabeth A Platz; Dominique S Michaud Journal: JNCI Cancer Spectr Date: 2021-04-19